{"id":12866,"date":"2019-06-04T23:42:06","date_gmt":"2019-06-04T21:42:06","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/"},"modified":"2020-09-16T16:36:35","modified_gmt":"2020-09-16T14:36:35","slug":"origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum","status":"publish","type":"gco_media","link":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/","title":{"rendered":"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

Origenis GmbH Announces Research Collaboration with U.S. Cancer Center<\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine-lead”]<\/p>\n

Origenis AI Discovery Platform to Identify and Optimize Small Molecule\u00a0Preclinical Development Candidates for Glioblastoma<\/p>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]06\/04\/2019[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner width=”2\/3″ offset=”vc_col-lg-6 vc_col-md-6″][vc_column_text]<\/p>\n


\nPressemeldung als PDF downloaden<\/span><\/a><\/div>\n

[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″ offset=”vc_col-lg-6 vc_col-md-6″][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]Martinsried, Germany, June 4, 2019 \u2013 Origenis GmbH, a privately-held German biopharmaceutical company with a proprietary platform for AI drug discovery and development, today announced that the company has entered into a collaboration with Memorial Sloan Kettering Cancer Center (MSK), New York, targeting glioblastoma (GBM), a rare but fatal brain cancer.<\/strong><\/p>\n

Under the research and collaboration agreement, Origenis will use its proprietary AI platform for drug discovery and development. With its intelligent selection and decision making processes, the platform allows identification of non-obvious connections between targets, chemical compounds and their specific properties to turn early leads into promising drugs candidates. The platform features Cippix\u00ae, a unique tool for evolutionary learning with data extracted from patents, alongside proprietary biology and chemical knowledge, and the alignment of novel compounds to targets with real-life chemical synthesis routes using MolMind\u00ae.<\/span><\/p>\n

In this collaboration, Origenis and MSK will work together to identify and optimize a novel series of small molecules to inhibit GBM, among the most fatal of cancers. Although GBM are not the most commonly occurring cancers, they are among the most deadly because of the challenge of ensuring drug delivery through the blood brain barrier.<\/span><\/p>\n

\u201cWe welcome this opportunity to collaborate with Memorial Sloan Kettering, one of the world\u2019s leading cancer research facilities, to utilize our proven platform for discovering and synthesizing novel small molecules that can cross the blood brain barrier,\u201d said Michael Almstetter, Chief Executive Officer, Origenis. \u201cWe look forward to pairing their cancer expertise with our unique approach to creating better Preclinical Development Candidates more directly and quickly.\u201d<\/span><\/p>\n

About Origenis GmbH<\/strong>
\nOrigenis GmbH is a privately-held German biopharmaceutical company with a proprietary platform for AI drug discovery and development, resulting in significant IP generation and strong patent protection. Origenis\u2019 unique approach to small molecule medicines creates better Preclinical Development Candidates (PDCs) faster by identifying non-obvious connections between targets, chemical compounds and the specific properties needed to make them promising drugs candidates. The platform features Cippix\u00ae, a unique tool for evolutionary learning with data extracted from patents; MolMind\u00ae for optimal decisions and minimal attrition; MOREsystem\u00ae for the alignment of novel compounds to targets with real-life chemical synthesis routes and BRAINstorm™ for ensuring brain penetration and ADME-tox feedback. The Origenis platform has been validated by multiple partners. For more information, visit www.origenis.com<\/a>.<\/span><\/p>\n

For further information please contact:<\/span><\/strong><\/p>\n

Michael Almstetter, CEO
\nTel: +49 (0)89 780 16 760
\nE-Mail: michael.almstetter@origenis.com<\/span><\/p>\n

Dr. Peter Seufer-Wasserthal, CBO
\nTel: +49 (0)89 780 16 760
\nE-Mail: peter.seufer@origenis.com<\/span><\/p>\n

[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"featured_media":1653,"template":"","meta":{"_links_to":"","_links_to_target":""},"media-categories":[7432,7431],"class_list":["post-12866","gco_media","type-gco_media","status-publish","has-post-thumbnail","hentry","media-categories-press-release","media-categories-press-release-izb-martinsried"],"yoast_head":"\nOrigenis GmbH Announces Research Collaboration with U.S. Cancer Center - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center\" \/>\n<meta property=\"og:description\" content=\"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center Origenis AI Discovery Platform to Identify and Optimize Small Molecule\u00a0Preclinical\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-16T14:36:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/03\/origenis_Start-Up-im-IZB.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"80\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\\\/\",\"name\":\"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/origenis_Start-Up-im-IZB.jpg\",\"datePublished\":\"2019-06-04T21:42:06+00:00\",\"dateModified\":\"2020-09-16T14:36:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/origenis_Start-Up-im-IZB.jpg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/origenis_Start-Up-im-IZB.jpg\",\"width\":400,\"height\":80},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/mediathek\\\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PRESS RELEASE\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/media-library\\\/press-release\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Press release standard\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/media-library\\\/press-release\\\/press-release-izb-martinsried\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/","og_locale":"en_US","og_type":"article","og_title":"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center","og_description":"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center Origenis AI Discovery Platform to Identify and Optimize Small Molecule\u00a0Preclinical","og_url":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_modified_time":"2020-09-16T14:36:35+00:00","og_image":[{"width":400,"height":80,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/03\/origenis_Start-Up-im-IZB.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/","url":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/","name":"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/03\/origenis_Start-Up-im-IZB.jpg","datePublished":"2019-06-04T21:42:06+00:00","dateModified":"2020-09-16T14:36:35+00:00","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/03\/origenis_Start-Up-im-IZB.jpg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/03\/origenis_Start-Up-im-IZB.jpg","width":400,"height":80},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/mediathek\/origenis-gmbh-meldet-forschungskooperation-mit-us-krebszentrum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"PRESS RELEASE","item":"https:\/\/www.izb-online.de\/en\/media-library\/press-release\/"},{"@type":"ListItem","position":3,"name":"Press release standard","item":"https:\/\/www.izb-online.de\/en\/media-library\/press-release\/press-release-izb-martinsried\/"},{"@type":"ListItem","position":4,"name":"Origenis GmbH Announces Research Collaboration with U.S. Cancer Center"}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_media\/12866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_media"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/gco_media"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/1653"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=12866"}],"wp:term":[{"taxonomy":"media-categories","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media-categories?post=12866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}